INTRODUCTION
Accessory sexual gland function as well as sexual behaviour are among the processes that are maintained by the action of testicular androgens in male mammals including man. Prevention of access by androgens to these targets, either surgically or chemically, results in impairment or even abolition of their normal function.
Cyproterone or its acetate has been claimed to inhibit any effects of endo¬ genous or exogenous androgens (Neumann, von Berswordt-Wallrabe, Elger, Steinbeck, Hahn & Kramer, 1970) , presumably in the main by competitive antag¬ onism. Differences in the actions of these steroids on different androgen-dependent targets may be due to species differences. Inhibition of libido in sexually naive rats (Steinbeck, Elger & Neumann, 1967) as well as complete lack of influ¬ ence in sexually experienced rats and guinea-pigs (Zucker, 1966; Beach & Westbrook, 1968; Whalen & Edwards, 1969; or even stimulatory effects (Davidson & Bloch, 1969) (Laschet & Laschet, 1967a, b; Laschet, Laschet, Fetzner, Glaesel, Mall & Naab, 1967; Giese, Krause & Schmidt, 1968; Hoffet, 1968; Ott, 1968; Seebandt, 1968) .
There (Hohlweg, 1956 In the second experiment, the same regimen of treatment, fertility tests and autopsy was applied, except that the doses of cyproterone acetate were 2-5 mg/animal (sixty animals), while those of cyproterone were 10-0 mg/animal (thirty-four animals) and of oestradiol, 0-25 mg/animal (sixty animals). The treatment period lasted for 6 weeks and the recovery period for 12 weeks.
RESULTS
The differences in the results of treatment with cyproterone, its acetate and (Voigt, Apostolakis & Klosterhalfen, 1968) .
It is, however, difficult to explain why spermiogenesis was decreased when the Leydig cells were over-stimulated after 3 weeks of treatment and returned to normal by 6 weeks when the interstitium no longer showed signs of hyper¬ trophy. Differing latencies in the response of spermatogenesis and interstitial tissue to changes in the hormonal environment might be involved.
The return of the appearance of the interstitial tissue to normal can be ex¬ plained by the assumption that gradually increasing circulating levels of testo¬ sterone resulting from increased gonadotrophin secretion finally overcame part of the antagonism on the feedback receptors with an eventual partial reversal of the increased gonadotrophin secretion. As a result, Leydig cell hypertrophy ceased to be manifested.
Since these experiments were terminated, similar conclusions have also been stated by other authors in two recent publications Mietkiewski, Malendowicz & Lukaszyk, 1969) , although no data on accessory sexual glands were reported. In their studies, only 10-0 mg cyproterone/animal/day were administered, a dose that had no effect on the testis in our experiments. This discrepancy could be due to strain differences and possibly also to differences in body weight which were not reported.
The distinct inhibition of spermiogenesis in the presence of normal inter¬ stitial tissue during treatment with cyproterone acetate can also be explained by the antiandrogenic action of this steroid at the level of the germinal epithelium. Since androgen probably reaches the seminiferous tubules in higher concentration than in peripheral blood, it is understandable that less antagonism at this target site might be observed with a given dose of anti¬ androgen than would be the case for seminal vesicles or prostates. Since cypro¬ terone acetate treatment does not result in Leydig cell overstimulation, it might be argued that this antiandrogen is unable to overcome the blood-brain barrier (Whalen & Edwards, 1969; Whalen, Luttge & Green, 1969; Edwards, 1970) . There is, however, some Leydig cell suppression along with increasing inhibition of spermiogenesis after prolonged treatment and this steroid is also capable of blocking ovulation in rats. In men, cyproterone acetate treatment resulted in severe Leydig cell suppression (Markewitz, Veenema, Fingerhut, Nehme-Haily & Sommers, 1969 ) and a marked decrease of plasma testosterone levels (Geller, Vazakas, Fruchtman, Newman, Nakao & Loh, 1968 .
Even if the main antifertility effect of the compound is related to impairment or atrophy of the accessory sexual glands and only partly to an arrest of sperma-togenesis, this would be undesirable for normal men since the volume of ejaculate would be likely to be reduced. It also seems possible that the penis might be affected for cyproterone acetate has been reported to cause damage to the penile papillae in rats (Davidson, Bloch, Smith & Weick, 1970) . Moreover, the influence of cyproterone acetate is not only restricted to the male reproduc¬ tive organs but is of a more generalized nature, including effects on such remote androgen targets as enzyme distribution patterns in liver and kidney, sebaceous glands and other organs (see Neumann et al., 1970) .
The main objection to the use of cyproterone acetate in healthy men is its distinct suppressive effect on sex drive which has been proved in a great number of patients (Laschet & Laschet, 1967a, b; Laschet et al., 1967; Giese et al., 1968; Hoffet, 1968; Ott, 1968; Seebandt, 1968) , although animal studies failed to show libido inhibition (Zucker, 1966; Beach & Westbrook, 1968; Whalen & Edwards, 1969; .
